GAITHERSBURG, Md., May 3 /PRNewswire/ -- MaxCyte, Inc., a clinical stage therapeutics company and pioneer in cell loading systems, announces a panel session on stem cell therapeutics entitled, “Delivering the Promise of Stem Cell Therapeutics?” will take place at BIO 2007 -- the Biotechnology Industry Organization’s annual meeting and convention. The meeting is being held May 6- 10, 2007 in Boston, Massachusetts. Scheduled for 9:15 a.m., Monday, May 7, 2007, the session will evaluate the current state of stem cell therapies and the potential for engineering stem cells as a method of developing better, more potent therapies. The session will include a discussion of the regulatory issues surrounding existing and engineered stem cell therapies, as well as specific company initiatives in the development of stem cell-based therapeutics.
